Trials / Withdrawn
WithdrawnNCT01213810
Prevention of Varicella Zoster Virus (VZV)-Reactivation in HIV-positive Individuals Enrolled in a Prospective Immunogenicity and Safety Trial of VZV Vaccine: PROVE-IT-Study
- Status
- Withdrawn
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Zurich · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal is to demonstrate the immunogenicity and safety of Zostavax® in HIV positive individuals. Study participants are stratified into different patient groups according to their CD4 cell count, viral load and HIV Status. * Trial with medicinal product * Trial with immunomodulatory product / biological
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Zostavax | Biological/Vaccine |
Timeline
- Start date
- 2010-12-01
- Primary completion
- 2011-12-01
- Completion
- 2012-06-01
- First posted
- 2010-10-04
- Last updated
- 2013-03-01
Source: ClinicalTrials.gov record NCT01213810. Inclusion in this directory is not an endorsement.